HC-2024-0086-V486

Type II variation for application HC-2024-0086. Type II variation: Formulation Change for Dupitumacon — routine update

Variation Number
HC-2024-0086-V486
Type
Type II
Application
HC-2024-0086
Change
CHG-2023-0186
Status
Overdue
Fee
€46,225
Submitted
2023-05-13
Approved
—
Description

Type II variation: Formulation Change for Dupitumacon — routine update